The latest genitourinary oncology news
Prognostic model development and molecular subtypes identification in bladder urothelial cancer
A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US”…
The latest genitourinary oncology news
A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US”…
A UC Davis Health study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis…
A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU…
Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis,…
Patient-reported outcomes are important indicators of how cancer drugs impact patients’ lives. By assessing the…
Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have…
Subcutaneous injection of the immunotherapy nivolumab is non-inferior to intravenous delivery and dramatically reduces treatment…
Patients with metastatic castration-resistant prostate cancer (mCRPC) with extrapelvic nodal or visceral metastasis who were…
More than 65,000 men fall ill with prostate cancer each year in Germany. Twelve thousand…
Considering the molecular subtype of muscle-invasive bladder cancer (MIBC) based on differences in tumour RNA…